SARS-CoV-2-IN-35

Modify Date: 2025-08-22 13:03:51

SARS-CoV-2-IN-35 Structure
SARS-CoV-2-IN-35 structure
Common Name SARS-CoV-2-IN-35
CAS Number 2757763-47-4 Molecular Weight 621.67
Density N/A Boiling Point N/A
Molecular Formula C29H34F3N5O5S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SARS-CoV-2-IN-35


SARS-CoV-2-IN-35 is a potent and orally active SARS-CoV-2 M pro inhibitor with a Ki value of 12.1 nM. SARS-CoV-2-IN-35 can be used in research of COVID-19[1].

 Names

Name SARS-CoV-2-IN-35

 SARS-CoV-2-IN-35 Biological Activity

Description SARS-CoV-2-IN-35 is a potent and orally active SARS-CoV-2 M pro inhibitor with a Ki value of 12.1 nM. SARS-CoV-2-IN-35 can be used in research of COVID-19[1].
Related Catalog
In Vivo SARS-CoV-2-IN-35 (compound 5; 10 mg/kg; p.o.) has good oral utilization in Wistar-Han rats[1]. Animal Model: Wistar-Han rats[1] Dosage: 10 mg/kg Administration: Oral administration Result: Had oral F of 33 %.
References

[1]. Owen DR, et, al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021 Dec 24;374(6575):1586-1593.  

 Chemical & Physical Properties

Molecular Formula C29H34F3N5O5S
Molecular Weight 621.67
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.